AlphAIAlphAI — Financial news for AI agents
yahoo.comSEP 133 min read$TLRY

Tilray Trades Below $5 With Record Fiscal Revenue on the Books. What's Holding the Stock Back?

Tilray Brands (TLRY) reported record fiscal 2026 revenue of $915M but remains unprofitable, with a $1.09 per share loss. The company is diversifying into alcoholic beverages and CBD products, aiming to become a consumer staples company. Despite growth, its small market cap and ongoing losses make it a high-risk investment.

Original reporting
yahoo.com
Published Sep 13, 2026, 1:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 13, 2026, 1:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Tilray Trades Below $5 With Record Fiscal Revenue on the Books. What's Holding the Stock Back? — source image
Source · yahoo.com
Decision brief

The 30-second read

$TLRYNeutralLow
01

Why it matters

The earnings release provides fresh data on revenue growth and loss reduction, but profitability remains elusive, limiting immediate trading impetus.

02

Market read

Tilray's earnings update is relevant for investors tracking cannabis sector turnarounds and consumer‑goods diversification plays.

03

What to watch

Potential synergies from the BrewDog acquisition and upcoming product launches are not fully priced in.

Relevance 6/10Novelty 5/10Timing: post‑earnings release

Background

Tilray Brands, a former pure‑play cannabis company, is pivoting toward consumer packaged goods, reporting record revenue but still posting a loss.

Company-level read

Ticker impact

$TLRYNeutralMedium confidence
Context

Tilray reported record fiscal 2026 revenue of $915 million and a loss of $1.09 per share, improving from a $24.56 loss in 2025.

Expected impact

Modest upside potential if profit margins improve; downside risk if losses persist.

Evidence & confidence

Revenue growth shows progress, but the company remains unprofitable and small, limiting immediate price impact.

Market effects

Sector

Highlights challenges for cannabis‑related consumer staples transitioning to broader consumer goods.

Regional

Limited to North American cannabis and beverage markets.

Global

Minimal global impact; primarily relevant to niche investors.

Counterpoint

What could challenge this read

Despite losses, the diversification into beverage and CBD could position Tilray for a breakout if execution accelerates.

Key entities

  • Company
    Tilray Brands

    NASDAQ‑listed cannabis and consumer goods company.

  • Company
    BrewDog

    Craft‑brew brand acquired by Tilray.

Read at source← All news

Related articles

AUG 24
$CURLFHighAI 9/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf has made an unsolicited bid for Aurora Cannabis, offering a 45% premium. Aurora has not accepted the deal. Tilray Brands and Canopy Growth are also engaging in consolidation. Aurora recently acquired Safari Flower, while Canopy bought MTL Cannabis. Tilray is diversifying into alcohol and CBD. Investors should consider risks of consolidation strategies.

aol.com3 min
AUG 23
$TLRYMed

Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying?

Tilray Brands reported record fiscal 2026 revenue of $915 million, up 11%, and adjusted EBITDA of $61.1 million, also up 11%. Adjusted net income nearly doubled to $12.2 million, but missed analyst estimates. GAAP net loss was $49.6 million. Management expects fiscal 2027 adjusted EBITDA of $68M-$75M. Cannabis sales represent 29% of total revenue.

yahoo.com3 min
AUG 21
$CURLFHighAI 8/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf (CURLF) has made an unsolicited bid for Aurora Cannabis (ACB), offering a 45% premium. Aurora's response was noncommittal. Canopy Growth (CGC) and Tilray Brands (TLRY) are also consolidating, with Tilray expanding into alcohol and CBD. Investors may benefit from acquisitions, but risks include integration challenges and leverage.

fool.com3 min
AUG 7
$TLRYMed

Tilray Brands (TLRY) Is Up 5.7% After Narrower Loss, ESOP Shelf Filing and M&A Signal

Tilray Brands reported Q4 sales of US$281.71 million and full-year sales of US$915.45 million for the year ended May 31, 2026, with a substantially smaller net loss than the prior year. The company also filed a US$47.69 million shelf registration for 11,355,231 common shares tied to its ESOP. Management said at-the-market equity proceeds may fund acquisitions, including deals like BrewDog.

simplywall.st7 min
JUL 30
$TLRYMed

Tilray Brands Q4 Earnings Call Highlights

Tilray Brands (NASDAQ: TLRY) reported fiscal 2026 results on its Q4 earnings call. Net loss narrowed to $105.2M ($1.09/share) from about $2.2B in fiscal 2025. Adjusted net income rose 87% to $12.2M. Cannabis and distribution revenue grew, BrewDog added beverage revenue, and Tilray guided adjusted EBITDA of $68M to $75M for fiscal 2027.

yahoo.com6 min